Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD

Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)

NCT05966025 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD

NCT07313007 ·Status: NOT_YET_RECRUITING ·Phase: NA

Benefits of Trimetazidine in MASLD Patients

NCT06140953 ·Status: COMPLETED ·Phase: PHASE2

Plasma Betatrophin Levels in Non-alcoholic Fatty Liver Disease

NCT02176811 ·Status: COMPLETED

Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults NAFLD Patients (DELI_NAFLD Study)

NCT05804422 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)

NCT06836609 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

NCT05395481 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Role of Obeticholic Acid in the Patients of NAFLD With Raised ALT

NCT03836937 ·Status: COMPLETED ·Phase: NA

A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH

NCT06692283 ·Status: WITHDRAWN ·Phase: PHASE3

Investigation of Synbiotic Treatment in NAFLD

NCT01680640 ·Status: COMPLETED ·Phase: NA

Patients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study

NCT07188220 ·Status: RECRUITING

Non Alcoholic Fatty Liver Disease Influence of Statin Therapy

NCT00375349 ·Status: WITHDRAWN ·Phase: NA

Development of Microbial Therapeutics for Metabolic-associated Fatty Liver Disease: From Mechanistic Investigations to Clinical Trials

NCT06873165 ·Status: RECRUITING ·Phase: NA

Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver Disease

NCT05768334 ·Status: COMPLETED ·Phase: PHASE3

Study of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Sohag University Employees

NCT06536933 ·Status: NOT_YET_RECRUITING

Efficacy of a Natural Components Mixture in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)

NCT02369536 ·Status: COMPLETED ·Phase: NA

Probiotic Supplement Versus Placebo for the Treatment of Patients With Non-alcoholic Fatty Liver Disease

NCT06491342 ·Status: COMPLETED ·Phase: NA

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

NCT07068191 ·Status: RECRUITING ·Phase: NA

Development of a Novel Asian Mediterranean Diet and Its Acceptability in NAFLD

NCT06321211 ·Status: COMPLETED

The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

NCT06773221 ·Status: NOT_YET_RECRUITING ·Phase: NA

The Effect of GLP-1 Analogues on Liver Steatosis and Fibrosis in Diabetic and Obese Patients in a Clinical Setting

NCT07021443 ·Status: COMPLETED

Evaluate the Efficacy and Safety of LivPhcD Capsules in the NAFLD Subjects

NCT05930093 ·Status: RECRUITING ·Phase: NA

The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease

NCT05364684 ·Status: COMPLETED ·Phase: PHASE2

Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial

NCT06798948 ·Status: RECRUITING ·Phase: PHASE2

Assessment of Non-Invasive Testing in Major Liver-Related Outcomes

NCT06986447 ·Status: ENROLLING_BY_INVITATION